Belfast-based contract research firm’s Optimal platform is designed to capture the entire human antibody repertoire ...

Having successfully taken hundreds of projects through the critical early discovery stages, and drawing on an array of innovative services and proprietary platforms, Fusion Antibodies is well ...

In an update to the stock exchange, Fusion Antibodies said it had enjoyed a ‘marked improvement’ in sales in the current ...

Pharmaceutical company Fusion Antibodies said it had a “challenging” year but has seen its sales pipeline grow. Fusion posted audited revenue of £1.14m for the year ended March 2024 ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...

INNOVENT BIO (01801.HK) is working with a consultant to gauge the interest of global pharmaceutical companies in its ...